Smart needle company Injeq enters Nordic market

FREE FOR PUBLICATION 3.2.2022

The Finnish smart needle company Injeq Oy has signed a distributor contract with the Swedish company Nords Medical. The agreement gives Injeq access to Finland, Sweden, Norway and Denmark, which covers almost 10 percent of the total EU market.

The aim of the IQ-Tip® smart needle is to improve patient safety in lumbar punctures, where spinal fluid is sampled, or when drugs are administered into the spinal cavity. The smart needle tells you in real time when the tip of the needle reaches the cerebrospinal fluid, increasing the likelihood of a successful puncture.

Nordic market is very important for Injeq and the agreement with Nords Medical is a step in line with the strategy. Nords Medical has streamlined logistics covering the whole of the Nordic region. Nords Medical’s product portfolio consists of neuromonitoring, microdialysis, spinal surgery and pain management equipment.

Injeq’s distributor strategy is to partner with innovative medium-sized or smaller companies that know their customers personally. A company entering the market as a partner of a large distributor may not get sufficient input for its products but is one representation among others.

“We first considered about having a distributor for each Scandinavian country separately until Nords Medical contacted us. Nords Medical is appropriately sized, active and operates in all Nordic countries except in Island. The company is well managed and has grown rapidly in recent years”, says Seppo Lautamäki, Injeq’s Sales Director.

Nords Medical works with the largest hospitals in the Nordic countries, such as university hospitals, where pediatric leukemias are also most commonly treated and where a significant portion of neonatology operates. “Our clients include the university hospitals in Helsinki, Turku, Tampere, Kuopio and Oulu. Injeq and Nords Medical aim to provide a solution that benefits both patients and physicians and improves healthcare”, emphasizes Olof Nord, CEO of Nords Medical. In December, the IQ-Tip® smart needle received CE certification from the EU’s notified body, TÜV SÜD Product Service GmbH. This enables the devices to be sold in EU countries. The global market for special needles is projected to grow from approximately $ 9.5 billion (2020) to $ 16.9 billion by 2027. The estimated annual growth is 8.5 percent.

For further information, please contact:

Injeq Oy
Seppo Lautamäki, VP Sales
tel. 040 5560 166
seppo.lautamaki@injeq.com

Nords Medical
Olof Nord, CEO
tel. + 46 7663 16550
olof@nordsmedical.com

 

Injeq in brief

Injeq Oy is a Finnish growth company in innovative medical technology, whose mission is to produce technically intelligent solutions for medically demanding patient injections. Developed at the request of physicians, the IQ-Tip® smart needle facilitates physicians’ work to improve patient safety and treatment effectiveness. The IQ-Tip® smart needle is a modern way to perform demanding patient injections safely. The first stage is lumbar puncture, a clinical procedure in which the spinal fluid is sampled or a drug is administered into the spinal cavity. The clinical performance and safety of the product at lumbar punctures have been evaluated in three clinical trials in Finnish university hospitals. The smart needle is suitable for lumbar puncture from newborns to the elderly, one of the main uses being for the treatment of leukemia children. Founded in 2010, Injeq operates in Tampere and currently employs 16 people. Injeq is supported by an experienced team of medical experts and extensive scientific research. IQ-Tip® is a registered trademark of Injeq.

 

 

Injeq is one of the Europe’s Top 5 Medical Device Companies to Watch in 2023

Healthcare advancements that were mere ideas decades ago are coming to fruition, proving to be much more valuable to saving […]
Read more »

The 3rd part of Sievänen’s trilogy about traumatic lumbar punctures is out now: Incidence of traumatic lumbar punctures in adults: the impact of a patient’s first procedure

We are happy to announce that the last part of Sievänen’s traumatic lumbar punctures’ trilogy is now published. Two factors […]
Read more »

Päivi Lehtonen starting as Injeq’s new Sales Director in April

The current CEO of Teivo, Päivi Lehtonen, will start as Injeq’s new Sales Director in the beginning of April. Päivi […]
Read more »

We are excited to join the biggest German neurology event Neurowoche 2022

We are excited to join the biggest annual German neurology event Neurowoche 2022 with our distributor Ecumed. The congress takes […]
Read more »

Injeq participating Italian Neonatology congress SIN

Injeq is happy to join our Italian distributor Euromed at SIN – XXVIII Italian Neonatology Congress in beautiful Firenze. Come […]
Read more »

Injeq participating SIOP 2022 in Barcelona 28th September -1st October

Injeq is very excited to attend the SIOP Congress to present our amazing IQ-Tip system to doctors, patients and their […]
Read more »